| |
| | (4) Rheumatoid arthritis: management with DMARDs |
 | | DMARDs are the most important agents used to treat rheumatoid arthritis as they suppress symptoms, delay joint damage and potentially delay deformity. |
 | | In the meantime, patients with a suspected diagnosis of rheumatoid arthritis should be referred promptly to a specialist centre where their diagnosis can be confirmed and appropriate treatment started without delay, based on a careful evaluation of efficacy and potential toxicity in the individual patient. |
 | | Finally, patients with very active disease and poor predictive outcomes, such as high inflammatory markers, large joint involvement and strong seropositivity, may be treated with combination therapy from the outset, for example, parenteral pulse methylprednisolone, oral weekly methotrexate, and daily cyclosporin as well as intra-articular steroid injections to all their inflamed large joints. |
| www.pharmj.com /Editorial/19990731/education/dmards.html (5855 words) |
|